CROSBY Research – Natural Food International (1837 HK/BUY): Continue to build up its new channel business

30 Mar 2023 NFI’s FY22 topline was up by 6.8% YoY to Rmb1,719m. Offline sales, ...

CROSBY Research – Tai Hing (6811 HK): Benefiting from the return of tourists

29 Mar 2023 Tai Hing’s FY22 revenue declined by 15.7% YoY to HK$2.68bn, with revenues ...

CROSBY Research – China Suntien Green Energy (956 HK/BUY): In-line FY22 results, expect LSD NG sales volume growth in FY23

28 Mar 2023 FY22 revenue was up by 15.0% YoY to Rmb18.6bn, mainly due to ...

CROSBY Research – Wasion Holdings (3393HK/BUY): FY22 marked a remarkable year

28 Mar 2023 Wasion’s FY22 NP increased by 20.8% YoY to Rmb323.8m on the back ...

CROSBY Research – China Everbright Greentech (1257 HK/BUY): Inline FY22 results

27 Mar 2023 CEG’s FY22 revenue was down by 5% YoY to HK$8,048m, mainly driven ...

CROSBY Research – Crosby Bi-noculars (Bi-weekly Issue 32)

27 Mar 2023 Hong Kong on Friday announced new measures on developing family office businesses, ...

CROSBY Research – Canvest Environmental (1381 HK/BUY): Speeding up its “Incineration +” model

24 Mar 2023 FY22 revenue increased by 21.4% YoY to HK$8.25bn, mainly due to 1) ...

CROSBY Research – Xtep International (1368 HK/BUY): Inline FY22 results, increasing sales contribution from new brands

23 Mar 2023 Xtep’s FY22 revenue was up by 29.1% YoY to Rmb12,930m, mainly driven ...

CROSBY Research – Sunny Optical (2382 HK/BUY): Solid growth momentum driven by vehicle related business & AR/VR, maintained BUY rating

23 Mar 2023 Sunny reported 2H22 revenue decreased by 8.1% YoY to Rmb16,225m, dragged by ...

CROSBY Research – 361 Degrees (1361 HK/BUY): Solid FY22 results, Kids segment and online sales continue to drive growth

22 Mar 2023 FY22 revenue was up 17.3% YoY to Rmb7.0bn, with core brand retail ...

CROSBY Research – China Lesso (2128 HK/BUY): The emergence of new growth engine

21 Mar 2023 China Lesso’s FY22 turnover decreased by 4.0% YoY to Rmb30.8bn while NP ...

CROSBY Research – China Lilang (1234 HK): Expects at least 10% retail sales growth in FY23

21 Mar 2023 The company reported a 8.7% YoY decline in topline to Rmb3,086m in ...

CROSBY Research – Q-Tech Group (1478 HK/BUY): Automotive and IoT business become main growth driver, maintain BUY rating

20 Mar 2023 Q-Tech reported 2H22 revenue of Rmb6,664m, which decreased 28.5% YoY. 2H22 total ...

CROSBY Research – Stella International (1836 HK): Ramping up its capacity in the coming 3 years

20 Mar 2023 Stella’s FY22 revenue was up by 5.9% YoY to US$1,631m, mainly driven ...

CROSBY Research – Crosby Bi-noculars (Bi-weekly Issue 31)

13 Mar 2023 While the collapse in SVB will unlikely trigger another financial crisis, it ...

CROSBY Research – Concord New Energy (182 HK/BUY): Bodes well into the grid parity era

08 Mar 2023 CNE’s FY22 revenue was up by 22.0% YoY to Rmb2,679m, mainly due ...

CROSBY Research – Pentamaster International (1665 HK/BUY): Order book surged in 4Q22 driven by strong automotive and medical devices demand

02 Mar 2023 Pentamaster’s 4Q22 revenue increased 20.6% YoY from MYR122.4m in 4Q21 to MYR147.7m. ...

CROSBY Research – SIIC Environment (807 HK): Further expansion in GBA & YREB regions

01 Mar 2023 SIIC reported its FY22 result with an increase in revenue by 14.3% ...

CROSBY Research – Crosby Bi-noculars (Bi-weekly Issue 30)

27 Feb 2023 Christopher Hui, secretary for HKSAR financial services and the treasury, said on ...

CROSBY Research – Vincent Medical (1612 HK/Neutral): Weak respiratory sales and inventory pile-up dented bottom line

14 Feb 2023 Vincent Medical (VM) issued a profit warning citing that its FY22 reported ...